Pharmacotherapy of Pain in Older Adults

Clinics in Geriatric Medicine

Volumn 24, Issue 2, 2008, Pages 275-298

  Strassels, Scott A ^a   McNicol, Ewan ^b   Suleman, Rosy ^c  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALFENTANIL; BUTORPHANOL; CELECOXIB; CODEINE; CYCLOOXYGENASE 2 INHIBITOR; CYTOCHROME P450; DEXTROPROPOXYPHENE; DICLOFENAC; FENTANYL; HYDROMORPHONE; IBUPROFEN; KETOROLAC; METHADONE; MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 GLUCURONIDE; MORPHINE SULFATE; NALBUPHINE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; NORPETHIDINE; ORAMORPH SR; OXYCODONE; OXYMORPHONE; PARACETAMOL; PENTAZOCINE; PETHIDINE; ROFECOXIB; SALICYLIC ACID DERIVATIVE; TRAMADOL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AGED; AGING; ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIPYRETIC ACTIVITY; BLEEDING; CONSTIPATION; DEMOGRAPHY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG DEPENDENCE; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; DRUG TOLERANCE; DYSPHORIA; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL IRRITATION; GASTROINTESTINAL SYMPTOM; HUMAN; LIVER TOXICITY; NAUSEA; NEPHROTOXICITY; PAIN; PATHOPHYSIOLOGY; PHARMACODYNAMICS; PREVALENCE; PRURITUS; RESPIRATION DEPRESSION; REVIEW; URINE RETENTION; VOMITING;

AGED; ANALGESICS; HUMANS; PAIN;

EID: 41149170832     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cger.2007.12.011     Document Type: Review

References (84)

1. Middleton K.R., and Hing E. National Hospital Ambulatory Medical Care Survey: 2003 outpatient department summary. Advance data from vital and health statistics: no 366 (2005), National Center for Health Statistics, Hyattsville (MD)
2. Gureje O., Von Korff M., Simon G.E., et al. Persistent pain and well-being. A World Health Organization Study in primary care. JAMA 280 (1998) 147-151
3. Breivik H., Collett B., Ventafridda V., et al. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 10 (2006) 287-333
4. Inpatient procedures. Fast stats A to Z. Available at: http://www.cdc.gov/nchs/fastats/insurg.htm. Accessed August 6, 2007.
5. Cleeland C.S., Gonin R., Hatfield A.K., et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 330 (1994) 592-596
6. Carr D.B., Jacox A.K., Chapman C.R., et al. Clinical practice guideline number 1: acute pain management: operative or medical procedures and trauma (1992), Agency for Health Care Policy and Research, Rockville (MD) AHCPR publication no. 92-0032
7. Marks R.M., and Sachar E.J. Undertreatment of medical inpatients with narcotic analgesics. Ann Intern Med 78 (1973) 173-181
8. Donovan M., Dillon P., and McGuire L. Incidence and characteristics of pain in a sample of medical-surgical inpatients. Pain 30 (1987) 69-78
9. Sriwatanakul K., Weis O.F., Alloza J.L., et al. Analysis of narcotic analgesic usage in the treatment of postoperative pain. JAMA 250 (1983) 926-929
10. Warfield C.A., and Kahn C.H. Acute pain management: programs in US hospitals and experiences and attitudes among US adults. Anesthesiology 83 (1995) 1090-1094
11. Miaskowski C., Nichols R., Brody R., et al. Assessment of patient satisfaction utilizing the American Pain Society's quality assurance standards on acute and cancer-related pain. J Pain Symptom Manage 9 (1994) 5-11
12. SUPPORT Principal Investigators. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). JAMA 274 (1995) 1591-1598
13. Wolfe J., Grier H.E., Klar N., et al. Symptoms and suffering at the end of life in children with cancer. N Engl J Med 342 (2000) 326-333
14. Whelan C.T., Jin L., and Meltzer D. Pain and satisfaction with pain control in hospitalized medical patients. No such thing as low risk. Arch Intern Med 164 (2004) 175-180
15. Kehlet H. Surgical stress: the role of pain and analgesia. Br J Anaesth 63 (1989) 189-195
16. Gottschalk A., Smith D.S., Jobes D.R., et al. Preemptive epidural analgesia and recovery from radical prostatectomy. A randomized controlled trial. JAMA 279 (1998) 1076-1082
17. Kiecolt-Glaser J.K., Page G.G., Marucha P.T., et al. Psychological influences on surgical recovery: perspectives from psychoneuroimmunology. Am Psychol 53 (1998) 1209-1218
18. Coley K.C., Williams B.A., DaPos S.V., et al. Retrospective evaluation of unanticipated admissions and readmissions after same day surgery and associated costs. J Clin Anesth 14 (2002) 349-353
19. Cepeda M.S., Africano J.M., Polo R., et al. What decline in pain intensity is meaningful to patients with acute pain?. Pain 105 1-2 (2003) 151-157
20. Bonica J.J. Importance of effective pain control. Acta Anaesthesiol Scand 31 Suppl 85 (1987) 1-16
21. Carr D.B., and Goudas L. Acute pain. Lancet 353 (1999) 2051-2058
22. Kehlet H., and Holte K. Effect of postoperative analgesia on surgical outcome. Br J Anaesth 87 (2001) 62-72
23. Strassels S.A., Chen C., and Carr D.B. Postoperative analgesia: economics, resource use, and patient satisfaction in an urban teaching hospital. Anesth Analg 94 (2002) 130-137
24. Perkins F.M., and Kehlet H. Chronic pain as an outcome of surgery-a review of predictive factors. Anesthesiology 93 (2000) 1123-1133
25. Stewart W.F., Ricci J.A., Chee E., et al. Lost productive time and cost due to common pain conditions in the US workforce. JAMA 290 (2003) 2443-2454
26. Berger A., Dukes E.M., and Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain 5 (2004) 143-149
27. American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care 26 (2003) 917-932
28. Gordois A., Scuffham P., Shearer A., et al. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care 26 (2003) 1790-1795
29. Sleed M., Eccleston C., Beecham J., et al. The economic impact of chronic pain in adolescence: methodological considerations and a preliminary cost-of-illness study. Pain 119 (2005) 183-190
30. Morris D.B. The culture of pain (1993), University of California Press, Berkeley (CA)
31. Donabedian A. Evaluating the quality of medical care. Milbank Mem Fund Q 44 Suppl (1966) 166-206
32. Lasch K., Greenhill A., Wilkes G., et al. Why study pain? A qualitative analysis of medical and nursing faculty and students' knowledge of and attitudes to cancer pain management. J Palliat Med 5 (2002) 57-71
33. McNicol E. Pharmacy and pain management: much work left to do. J Am Pharm Assoc (2003) 4343-4344 [letter]
34. Pain. International Association for the Study of Pain. IASP pain terminology. Available at: www.iasp-pain.org. Accessed August 6, 2007.
35. Pasero C., Paice J.A., and McCaffery M. Basic mechanisms underlying the causes and effects of pain. In: McCaffery M., and Pasero C. (Eds). Pain: clinical manual. 2nd edition (1999), Mosby, St. Louis (MO) 15-34
36. In: Ready L.B., and Edwards W.T. (Eds). Management of acute pain: a practical guide (1992), IASP, Seattle (WA)
37. Savage S.R., Joranson D.E., Covington E.C., et al. Definitions related to the medical use of opioids: evolution towards universal agreement. J Pain Symptom Manage 26 (2003) 655-667
38. In: McMahon S.B., and Koltzenburg M. (Eds). Wall & Melzack's textbook of pain. 5th edition (2006), Elsevier Churchill Livingstone, London
39. McCaffery M. Pain control. Barriers to the use of available information. World Health Organization Expert Committee on Cancer Pain Relief and Active Supportive Care. Cancer 70 Suppl 5 (1992) 1438-1449
40. Drayer R.A., Henderson J., and Reidenberg M. Barriers to better pain control in hospitalized patients. J Pain Symptom Manage 17 (1999) 434-440
41. Porter J., and Jick H. Addiction rare in patients treated with narcotics. N Engl J Med 302 (1980) 123
42. Perry S., and Heidrich G. Management of pain during debridement: a survey of US burn units. Pain 13 (1982) 267-280
43. Brozovic M., Davies S.C., Yardumian A., et al. Pain relief in sickle cell crisis. Lancet 2 (1986) 624-625
44. Vichinsky E.P., Johnson R., and Lubin B.H. Multidisciplinary approach to pain management in sickle cell disease. Am J Pediatr Hematol Oncol 4 (1982) 328-333
45. Pegelow C.H. Survey of pain management therapy provided for children with sickle cell disease. Clin Pediatr 31 (1992) 211-214
46. Passik S.D., and Kirsh K.L. The need to identify predictors of aberrant drug-related behavior and addiction in patients being treated with opioids for pain. Pain Med 4 (2003) 186-189
47. Ballantyne J.C., and LaForge K.S. Opioid dependence and addiction during opioid treatment of chronic pain. Pain 129 (2007) 235-255
48. Weissman D.E., and Haddox J.D. Opioid pseudoaddiction-an iatrogenic syndrome. Pain 36 (1989) 363-366
49. Bauer L.A. Clinical pharmacokinetics and pharmacodynamics. In: DiPiro J.T., Talbert R.L., Yee G.C., et al. (Eds). Pharmacotherapy: a pathophysiologic approach (2005), McGraw-Hill, New York 51-73
50. Lindblad C.I., Gray S.L., Guay D.R.P., et al. Geriatrics. In: DiPiro J.T., Talbert R.L., Yee G.C., et al. (Eds). Pharmacotherapy: a pathophysiologic approach (2005), McGraw-Hill, New York 103-113
51. Hammerlein A., Derendorf H., and Lowenthal D.T. Pharmacokinetic and pharmacodynamic changes in the elderly: clinical implications. Clin Pharmacokinet 35 (1998) 49-64
52. Sotaniemi E.A., Arranto A.J., Pelkonen O., et al. Age and cytochrome P-450-linked drug metabolism in humans. Clin Pharmacol Ther 61 (1997) 331-339
53. WHO's pain relief ladder. Available at: http://www.who.int/cancer/palliative/painladder/en/. Accessed August 6, 2007.
54. Salicylates. Facts & comparisons 4.0. Available at: http://online.factsandcomparisons.com. Accessed August 5, 2007.
55. Acetaminophen. Facts & comparisons 4.0. Available at: http://online.factsandcomparisons.com. Accessed August 5, 2007.
56. Draganov P., Durrence H., Cox C., et al. Alcohol-acetaminophen syndrome. Postgrad Med 107 (2000) 189-195
57. Buck M.L. Perioperative use of high-dose rectal acetaminophen. Pediatric Pharmacotherapy 7 (2001) 1-3
58. Birmingham P.K., Tobin M.J., Henthorn T.K., et al. Twenty-four-hour pharmacokinetics of rectal acetaminophen in children: an old drug with new recommendations. Anesthesiology 87 (1997) 244-252
59. Nonsteroidal anti-inflammatory drugs. Facts & comparisons 4.0. Available at: http://online.factsandcomparisons.com. Accessed August 5, 2007.
60. Moote C. Efficacy of nonsteroidal anti-inflammatory drugs in the management of postoperative pain. Drugs 44 (1992) 14-30
61. Celebrex package insert. Available at: http://www.celebrex.com/pdf/Celebrex_PI.pdf. Accessed August 4, 2007.
62. Schaefer M.G., Plowman B.K., Morreale A.P., et al. Interaction of rofecoxib and celecoxib with warfarin. Am J Health Syst Pharm 60 (2003) 1319-1323
63. Pasero C., Portenoy R.K., and McCaffery M. Opioid analgesics. In: McCaffery M., and Pasero C. (Eds). Pain: clinical manual. 2nd edition (1999), Mosby, St. Louis (MO) 161-299
64. Twycross R.G. Opioids. In: Wall P.D., and Melzack R. (Eds). Textbook of pain. 4th edition (1999), Churchill Livingstone, New York 1187-1214
65. Gutstein H.B., and Akil H. Opioid analgesics. In: Hardman J.G., Limbird L.E., and Gilman A.G. (Eds). Goodman and Gilman's the pharmacological basis of therapeutics. 10th edition (2001), McGraw-Hill, New York 569-619
66. Ashburn M.A., Lipman A.G., Carr D., et al. Principles of analgesic use in the treatment of acute pain and chronic pain. 5th edition (2003), American Pain Society, Glenview (IL)
67. Gammaitoni A.R., Fine P., Alvarez N., et al. Clinical application of opioid equianalgesic data. Clin J Pain 19 (2003) 286-297
68. Souter K.J., and Fitzgibbon D. Equianalgesic dose guidelines for long-term opioid use: theoretical and practical considerations. Seminars in anesthesia, perioperative medicine, and pain 23 (2004) 271-280
69. Latta K.S., Ginsberg B., and Barkin R.L. Meperidine: a critical review. Am J Ther 9 (2002) 53-68
70. Sporer K. The serotonin syndrome: implicated drugs, pathophysiology, and management. Drug Saf 13 (1995) 94-104
71. Michalets E.L. Update: clinically significant cytochrome P-450 drug interactions. Pharmacotherapy 18 1 (1998) 84-112
72. Inturrisi C.E. Clinical pharmacology of opioids for pain. Clin J Pain 18 (2002) S3-S13
73. Kamal-Bahal S.J., Doshi J.A., Stuart B.C., et al. Propoxyphene use by community dwelling and institutionalized elderly medicare beneficiaries. J Am Geriatr Soc 51 (2003) 1099-1106
74. Kamal-Bahl S.J., Stuar B.C., and Beers M.H. Propoxyphene use and risk for hip fractures in older adults. Am J Geriatr Pharmacother 4 (2006) 219-226
75. McQuay H., and Moore A. Dextropropoxyphene in postoperative pain. In: McQuay H., and Moore A. (Eds). An evidence-based resource in pain relief (1998), Oxford University Press, New York 132-137
76. Singh S., Sleeper R.B., and Seifert C.F. Propoxyphene prescribing among populations older and younger than age 65 in a tertiary care hospital. Consult Pharm 22 (2007) 141-148
77. McQuay H. Opioids in pain management. Lancet 353 (1999) 2229-2232
78. Sjogren P., Thunedborg L.P., Christrup L., et al. Is development of hyperalgesia, allodynia, and myoclonus related to morphine metabolism during long-term administration? Six case histories. Acta Anaesthesiol Scand 42 (1998) 1070-1075
79. Tiseo P.J., Thaler H.T., Lapin J., et al. Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients. Pain 61 (1995) 47-54
80. Kalso E., and Vainio A. Morphine and oxycodone hydrochloride in the management of cancer pain. Clin Pharmacol Ther 47 (1990) 639-646
81. Kaiko R.F., Foley K.M., Grabinski P.Y., et al. Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol 13 (1983) 180-185
82. Jacox A., Carr D.B., Payne R., et al. Management of cancer pain: clinical practice guideline no. 9 (1994), Agency for Health Care Policy and Research, Rockville (MD) AHCPR publication no. 94-0592
83. Macario A., Weinger M., Carney S., et al. Which clinical anesthesia outcomes are important to avoid? The perspective of patients. Anesth Analg 89 (1999) 652-658
84. McNicol E., Horowicz-Mehler N., Fisk R.A., et al. Management of opioid side effects in cancer-related and chronic noncancer pain: a systemic review. J Pain 4 (2003) 231-256